Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial

Related Experiment Video

Updated: Oct 9, 2026

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
10:02

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

Published on: March 12, 2020

L L Greenhill1, J M Swanson, B Vitiello

  • 1Clinical Psychiatry, Department of Psychiatry, Columbia University, New York, USA. LarryLGreenhill@cs.com

Journal of the American Academy of Child and Adolescent Psychiatry
|February 24, 2001
PubMed

Insights

The Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder (ADHD) found that a controlled methylphenidate (MPH) titration effectively identified optimal ADHD medication doses for children, showing significant improvements in behavior. This study confirmed MPH efficacy and established dosing guidelines.

Area of Science:

  • Child and Adolescent Psychiatry
  • Neurodevelopmental Disorders
  • Pharmacological Treatments

Background:

  • Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder in children.
  • Methylphenidate (MPH) is a widely prescribed stimulant medication for ADHD management.
  • Optimizing MPH dosage is crucial for maximizing treatment efficacy and minimizing adverse effects.

Purpose of the Study:

  • To evaluate the effectiveness of a double-blind, placebo-controlled methylphenidate (MPH) titration protocol in determining the optimal MPH dose for children with ADHD.
  • To analyze the impact of different MPH doses on behavioral outcomes as rated by teachers and parents.

Main Methods:

  • The study involved 289 children with ADHD assigned to medication treatment groups within the NIMH Collaborative Multisite Multimodal Treatment Study (MTA).
  • Participants underwent a 28-day controlled titration protocol, receiving placebo, low, middle, and high doses of MPH on successive days.
  • Teacher and parent ratings were used to assess behavioral impairment and deportment.

Main Results:

  • A significant main effect of MPH dose was observed, with greater improvements in teacher-reported impairment and deportment compared to parent ratings.
  • Effect sizes for MPH dose on teacher ratings ranged from 0.8-1.3, while on parent ratings, they ranged from 0.4-0.6.
  • No significant interactions were found between MPH dose and other factors like treatment period, dose order, comorbid diagnoses, study site, or treatment group.

Conclusions:

  • The MTA titration protocol successfully validated the efficacy of MPH dosing, including weekend administration.
  • A total daily dose limit of 35 mg of MPH was established for children weighing less than 25 kg.
  • The study replicated previous findings on MPH response rates (77%), optimal dose distribution (10-50 mg/day), and dose-related adverse events.
Abstract

More Related Videos

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...